{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T05:24:37Z","timestamp":1790659477772,"version":"4.1.0"},"reference-count":24,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2013,8,7]],"date-time":"2013-08-07T00:00:00Z","timestamp":1375833600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0072345","type":"journal-article","created":{"date-parts":[[2013,8,7]],"date-time":"2013-08-07T20:58:53Z","timestamp":1375909133000},"page":"e72345","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":40,"title":["Serum Levels of Fibroblast Growth Factor 19 Are Inversely Associated with Coronary Artery Disease in Chinese Individuals"],"prefix":"10.1371","volume":"8","author":[{"given":"Yaping","family":"Hao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojing","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhigang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meifang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoping","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junling","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqian","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiping","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,8,7]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1111\/j.1365-2796.2006.01731.x","article-title":"Circulating intestinal fibroblast growth factor 19 has a pronounced diurnal variation and modulates hepatic bile acid synthesis in man","volume":"260","author":"T Lund\u00e5sen","year":"2006","journal-title":"J Intern Med"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/hep.22627","article-title":"Bile acids activate fibroblast growth factor 19 signaling in human hepatocytes to inhibit cholesterol 7alpha-hydroxylase gene expression","volume":"49","author":"KH Song","year":"2009","journal-title":"Hepatology"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1517\/14728222.2011.624514","article-title":"Therapeutic utilities of fibroblast growth factor 19","volume":"15","author":"X Wu","year":"2011","journal-title":"Expert Opin Ther Targets"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/978-1-4614-0887-1_13","article-title":"Understanding the structure-function relationship between FGF19 and its mitogenic and metabolic activities","volume":"728","author":"X Wu","year":"2012","journal-title":"Adv Exp Med Biol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1210\/endo.143.5.8850","article-title":"Transgenic mice expressing human fibroblast growth factor-19 display increased metabolic rate and decreased adiposity","volume":"143","author":"E Tomlinson","year":"2002","journal-title":"Endocrinology"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1210\/en.2003-1671","article-title":"Fibroblast growth factor 19 increases metabolic rate and reverses dietary and leptin-deficient diabetes","volume":"145","author":"L Fu","year":"2004","journal-title":"Endocrinology"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1080\/00365510701854967","article-title":"Fibroblast growth factor-19: development, analytical characterization and clinical evaluation of a new ELISA test","volume":"68","author":"D Stejskal","year":"2008","journal-title":"Scand J Clin Lab Invest"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"627","DOI":"10.33549\/physiolres.932099","article-title":"Serum concentrations of fibroblast growth factor 19 in patients with obesity and type 2 diabetes mellitus: the influence of acute hyperinsulinemia, very-low calorie diet and PPAR-\u03b1 agonist treatment","volume":"60","author":"M Mr\u00e1z","year":"2011","journal-title":"Physiol Res"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.clinbiochem.2012.03.019","article-title":"Preliminary evidence of a reduced serum level of fibroblast growth factor 19 in patients with biopsy-proven nonalcoholic fatty liver disease","volume":"45","author":"F Eren","year":"2012","journal-title":"Clin Biochem"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/S0002-9149(83)80105-2","article-title":"A more meaningful scoring system for determining the severity of coronary heart disease","volume":"51","author":"GG Gensini","year":"1983","journal-title":"Am J Cardiol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0033-8389(22)02831-7","article-title":"Percutaneous transfemoral selective coronary arteriography","volume":"6","author":"MP Judkins","year":"1968","journal-title":"Radiol Clin North Am"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"DR Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"ref13","first-page":"390","article-title":"Fibroblast growth factor-19 levels in type 2 diabetic patients with metabolic syndrome","volume":"41","author":"B Barutcuoglu","year":"2011","journal-title":"Ann Clin Lab Sci"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1126\/science.1056843","article-title":"Continuous fatty acid oxidation and reduced fat storage in mice lacking acetyl-CoA carboxylase 2","volume":"291","author":"L Abu-Elheiga","year":"2001","journal-title":"Science"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"11482","DOI":"10.1073\/pnas.132384699","article-title":"Loss of stearoyl-CoA desaturaserase-1 function protects mice against adiposity","volume":"99","author":"JM Ntambi","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1210\/en.2004-0367","article-title":"Modulation of Metabolic Syndrome by Fibroblast Growth Factor 19 (FGF19)?","volume":"145","author":"AM Strack","year":"2004","journal-title":"Endocrinology"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"10023","DOI":"10.1074\/jbc.M808818200","article-title":"Fibroblast growth factor-19, a novel factor that inhibits hepatic fatty acid synthesis","volume":"284","author":"S Bhatnagar","year":"2009","journal-title":"J Biol Chem"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1055\/s-0029-1243249","article-title":"Fibroblast growth factor 19 serum levels: relation to renal function and metabolic parameters","volume":"42","author":"M Reiche","year":"2010","journal-title":"Horm Metab Res"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1210\/jcem.86.5.7463","article-title":"Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia","volume":"86","author":"C Weyer","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1074\/jbc.M209033200","article-title":"Globular adiponectin protected ob\/ob mice from diabetes and ApoE-deficient mice from atherosclerosis","volume":"278","author":"T Yamauchi","year":"2003","journal-title":"J Biol Chem"},{"key":"ref21","first-page":"78","article-title":"Serum adiponectin in patients with coronary heart disease","volume":"20","author":"SS Parul","year":"2011","journal-title":"Mymensingh Med J"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1210\/jc.2006-1067","article-title":"Serum adiponectin is a predictor of coronary heart disease: a population-based 10-year follow-up study in elderly men","volume":"92","author":"J Frystyk","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1016\/j.atherosclerosis.2006.08.028","article-title":"Increase in circulating levels of adiponectin after treatment with statin and fibrate in patients with coronary artery disease and hyperlipidemia.","volume":"193:","author":"T Nakamura","year":"2007","journal-title":"Atherosclerosis"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1007\/s11255-006-0039-9","article-title":"Incidence and risk factors of coronary heart disease in elderly patients on chronic hemodialysis","volume":"38","author":"LP Soubassi","year":"2006","journal-title":"Int Urol Nephrol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0072345","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,3]],"date-time":"2023-07-03T18:53:20Z","timestamp":1688410400000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0072345"}},"subtitle":[],"editor":[{"given":"Yan","family":"Gong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,8,7]]},"references-count":24,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2013,8,7]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0072345","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8,7]]}}}